This constant flow of information allows for continuous monitoring, ensuring patients stay on track and make adjustments as needed
10.1038/s41598-020-80063-0 124 ZhangX.LiY.YangP.LiuX.LuL.ChenY.et al (2020)
Detailed Initial Evaluation We begin our process with a thorough assessment of the patients current health, including their medical history, any existing conditions such as diabetes or thyroid disorders, personal habits, metabolic rate, weight, and personal objectives for weight loss
And the FDA and EMA the European drug regulator both reviewed the suicide signal in 2024 and found no causal link
Better Health Outcomes Lowered risk of obesity-related conditions such as diabetes and hypertension
Missing one dose does not stop Mounjaro or Wegovy from working